Because Victoza is widely prescribed for managing type 2 diabetes, understanding the potential risks between Victoza and thyroid cancer is essential for patients weighing their treatment options. Victoza (liraglutide) is a GLP-1 receptor agonist that helps control blood sugar and slows digestion. While highly effective, the medication carries a prominent FDA “Black Box Warning” specifically related to the risk of thyroid tumors, which often causes significant anxiety for newly diagnosed patients.
Page Contents
Quick Answer: Can Victoza Cause Thyroid Cancer?
There is a theoretical risk, but it has only been proven in rodents. In animal studies, liraglutide (the active ingredient in Victoza) caused thyroid C-cell tumors, including a rare type of cancer called medullary thyroid carcinoma (MTC), in rats and mice. It is currently unknown if Victoza causes thyroid C-cell tumors in humans, as human thyroid glands have fewer GLP-1 receptors than rodents. However, as a strict safety precaution, Victoza is contraindicated for anyone with a personal or family history of MTC or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
Understanding the FDA Black Box Warning
When patients search, “Does Victoza have cancer risk?” they often find the FDA’s Black Box Warning. This is the strictest warning put on prescription drugs by the FDA. The warning exists because the incidence of thyroid tumors in Victoza-treated rodents was dose-dependent and statistically significant. The FDA mandates this warning to ensure doctors screen patients’ family histories thoroughly before writing a prescription.
Symptoms to Watch For
- Neck Mass: A noticeable lump or swelling in the neck.
- Hoarseness: Unexplained voice changes or persistent hoarseness.
- Swallowing Difficulty: Feeling like a pill or food is stuck in your throat (dysphagia).
- Shortness of Breath: Unexplained breathing difficulties.
Does Victoza Cause Other Types of Cancer?
Another common concern is whether the drug increases the risk of other malignancies, such as pancreatic or breast cancer. Current clinical data does not show that Victoza directly causes pancreatic cancer, although it can cause acute pancreatitis (inflammation of the pancreas), which is a separate medical emergency. There is also no established link between Victoza and breast cancer. The specific oncological concern remains isolated to medullary thyroid carcinoma.
FAQ: Frequently Asked Questions
Does Victoza cause cancer in humans?
To date, there is no definitive proof that Victoza causes thyroid cancer or any other type of cancer in humans. The risk is based entirely on preclinical toxicity studies conducted on rodents.
What are the signs of thyroid tumors from Victoza?
If you are taking Victoza and experience a lump in your neck, chronic hoarseness, trouble swallowing, or shortness of breath, you should contact your doctor immediately for a thyroid evaluation.
Who should absolutely not take Victoza?
You must not take Victoza if you have a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2), or if you are allergic to liraglutide.
Should I get routine thyroid blood tests while on Victoza?
Routine monitoring of serum calcitonin or using thyroid ultrasounds is of uncertain value for early detection of MTC in patients on Victoza. Your doctor will rely more on physical neck examinations and your reporting of symptoms.
